Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19
Inflamm Bowel Dis
.
2020 Jun 18;26(7):e73.
doi: 10.1093/ibd/izaa114.
Authors
Antonio Tursi
1
,
Lorenzo Maria Vetrone
2
,
Alfredo Papa
2
3
Affiliations
1
Territorial Gastroenterology Service, Azienda Sanitaria Locale Barletta-Andria-Trani, Andria, Italy.
2
Division of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Rome, Italy.
3
Università Cattolica del S. Cuore, Rome, Italy.
PMID:
32382744
PMCID:
PMC7239106
DOI:
10.1093/ibd/izaa114
No abstract available
Publication types
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections
Humans
Inflammatory Bowel Diseases*
Italy
Pandemics
Pneumonia, Viral
SARS-CoV-2
Tumor Necrosis Factor-alpha*
Substances
Tumor Necrosis Factor-alpha